tiprankstipranks
Blurbs

Haemonetics (HAE) Receives a Hold from Needham

In a report released today, Michael Matson from Needham maintained a Hold rating on Haemonetics (HAEResearch Report). The company’s shares closed last Thursday at $55.37, close to its 52-week low of $43.50.

According to TipRanks.com, Matson is a 4-star analyst with an average return of 7.4% and a 50.7% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Cardiovascular Systems.

Haemonetics has an analyst consensus of Moderate Buy, with a price target consensus of $68.75, implying a 20.8% upside from current levels. In a report issued on February 9, Morgan Stanley also maintained a Hold rating on the stock with a $64.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Haemonetics’ market cap is currently $2.98B and has a P/E ratio of 131.70.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Read More on HAE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed